SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-24-058680
Filing Date
2024-05-08
Accepted
2024-05-08 16:17:18
Documents
15
Period of Report
2024-05-08
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2413698d2_8k.htm   iXBRL 8-K 33778
2 EXHIBIT 1.1 tm2413698d2_ex1-1.htm EX-1.1 234919
3 EXHIBIT 5.1 tm2413698d2_ex5-1.htm EX-5.1 55333
  Complete submission text file 0001104659-24-058680.txt   570701

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA avdl-20240508.xsd EX-101.SCH 3009
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE avdl-20240508_lab.xml EX-101.LAB 34240
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE avdl-20240508_pre.xml EX-101.PRE 22355
18 EXTRACTED XBRL INSTANCE DOCUMENT tm2413698d2_8k_htm.xml XML 3570
Mailing Address 16640 CHESTERFIELD GROVE ROAD SUITE 200 CHESTERFIELD MO 63005
Business Address BLOCK 10-1 BLANCHARDSTOWN CORPORATE PARK BALLYCOOLIN DUBLIN L2 15 636-449-1830
AVADEL PHARMACEUTICALS PLC (Filer) CIK: 0001012477 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37977 | Film No.: 24926345
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)